I-Flow Announces That Leading Institution Will Study Promise of a New Antimicrobial Benefit of ON-Q; ON-Q Therapy May Be Evolving to More Broadly Redefine Post-Surgical Recovery.
Linked as:
Extract
I-Flow Announces That Leading Institution Will Study Promise of a New Antimicrobial Benefit of ON-Q; ON-Q Therapy May Be Evolving to More Broadly Redefine Post-Surgical Recovery.
LAKE FOREST, Calif. -- I-Flow Corporation (NASDAQ:IFLO) announced today that the Company will partner with Tulane University Health Sciences Center to conduct an animal study to evaluate the antimicrobial benefits of ON-Q(R). If this research yields positive results, this may expand the use of ON-Q beyond tod...
See the full content of this document
Sponsored links
